DaVita Inc. (DVA)
DVA moved a median of +0.07% 30 minutes after news, and +0.22% by the close. How DVA actually reacts to news — the realized, point-in-time move the market made, measured across 339 labeled events over the last three years with zero look-ahead.
DVA’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | -0.01% | 43% | 339 |
| 30-min | +0.07% | 53% | 339 |
| 60-min | +0.05% | 50% | 339 |
| to close | +0.22% | 57% | 339 |
| Middle 50% of DVA reactions | -0.45% to +0.55% |
|---|---|
| Median reaction (30-min) | +0.07% |
| Measured reactions | 339 |
Half of all DaVita Inc. news events land between -0.45% and +0.55% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How DVA reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades | 17 | -0.01% | 41% | +1.02% |
| Analyst downgrades | 10 | -0.56% | 20% | +0.08% |
| Rating reiterations | 43 | -0.15% | 44% | +0.09% |
| Price-target raises | 16 | -0.11% | 44% | -0.01% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 2 further classes were observed with fewer than 10 measured events and are not published. See how DVA ranks against every other measured name →
That’s how DVA usually reacts — get an email when it moves on news →Email me when DVA moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to DVA's baseline. Nothing else.
Recent DVA events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| DaVita Brings New Clinical Research to ASN Kidney Week 2026, Advancing Evidence for the Next Era of Kidney Care | Press release | PR Newswire | -0.33% | +3.13% | |
| DaVita Activates Emergency Response Efforts Ahead of Hurricane Isaias, Urges Kidney Patients to Prepare Early | Press release | PR Newswire | +0.96% | +1.27% | |
| Alebund Pharmaceuticals Announces 2026 Interim Results | Press release | PR Newswire | +0.55% | +1.15% | |
| DaVita Announces New Value-Based Partnership with Humana to Expand Care for Patients with Chronic Kidney Disease | Press release | PR Newswire | +0.19% | -0.36% | |
| DaVita Inc. 2nd Quarter 2026 Results | Press release | PR Newswire | -6.39% | -8.07% | |
| Form 10-Q DAVITA INC. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -6.39% | -8.07% | |
| Form 8-K DAVITA INC. For: Aug 04 | SEC filing · Form 8-K | SEC EDGAR | -6.39% | -8.07% | |
| DaVita Inc. Schedules 2nd Quarter 2026 Investor Conference Call | Press release | PR Newswire | -0.20% | -2.12% | |
| Form 11-K DAVITA INC. For: Dec 31 | SEC filing · Form 11-K | SEC EDGAR | +0.17% | -2.00% | |
| Form 8-K DAVITA INC. For: Jun 04 | SEC filing · Form 8-K | SEC EDGAR | +0.93% | +2.35% | |
| DaVita Sets Bold 2030 Community Care Commitments After Exceeding Prior Five-Year ESG Goals | Press release | PR Newswire | +0.39% | -0.24% | |
| DaVita Inc. to Participate in the BofA Securities 2026 Health Care Conference | Press release | PR Newswire | -2.84% | +1.00% | |
| DaVita Inc. 1st Quarter 2026 Results | Press release | PR Newswire | +6.37% | +10.87% | |
| Form 10-Q DAVITA INC. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +6.37% | +10.87% | |
| Form 8-K DAVITA INC. For: May 05 | SEC filing · Form 8-K | SEC EDGAR | +6.37% | +10.87% | |
| Form ARS DAVITA INC. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +0.55% | +1.00% | |
| Form DEF 14A DAVITA INC. For: Dec 31 | SEC filing · Form DEF | SEC EDGAR | +0.55% | +1.00% | |
| Form DEFA14A DAVITA INC. | SEC filing · Form DEFA14A | SEC EDGAR | +0.55% | +1.00% | |
| DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call | Press release | PR Newswire | +0.14% | +0.20% | |
| DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement | Press release | PR Newswire | -0.40% | -1.35% | |
| Alebund Pharmaceuticals Announces Collaboration and License Agreement with R1 Therapeutics for AP306 | Press release | PR Newswire | +0.04% | +0.14% | |
| R1 Therapeutics launches with oversubscribed $77.5 million Series A financing to advance first-in-class treatment for hyperphosphatemia in patients with chronic kidney disease | Press release | GlobeNewswire | +0.04% | +0.14% | |
| DaVita Inc. to Participate in TD Cowen's 46th Annual Health Care Conference | Press release | PR Newswire | +0.02% | +0.63% | |
| Form 10-K DAVITA INC. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +1.77% | +3.90% | |
| DaVita Inc. 4th Quarter 2025 Results | Press release | PR Newswire | +6.17% | +5.26% | |
| Form 8-K DAVITA INC. For: Feb 02 | SEC filing · Form 8-K | SEC EDGAR | +6.17% | +5.26% | |
| DaVita Inc. Schedules 4th Quarter 2025 Investor Conference Call | Press release | PR Newswire | +0.33% | +0.85% | |
| Tolion Health AI Appoints Global Health & AI Leader Gregory J. Moore, MD, PhD, to Board of Directors | Press release | Business Wire | -0.14% | +0.98% | |
| DaVita Names New Leaders to Accelerate Care Transformation | Press release | PR Newswire | +0.72% | +0.80% | |
| Form 8-K DAVITA INC. For: Nov 24 | SEC filing · Form 8-K | SEC EDGAR | +0.17% | -1.01% | |
| DaVita Inc. to Participate in Fireside Chat with Wolfe Research | Press release | PR Newswire | -0.01% | -3.52% | |
| DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025 | Press release | PR Newswire | -0.18% | +0.98% | |
| DaVita Inc. 3rd Quarter 2025 Results | Press release | PR Newswire | -0.12% | -4.90% | |
| Form 10-Q DAVITA INC. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.12% | -4.90% | |
| Form 8-K DAVITA INC. For: Oct 29 | SEC filing · Form 8-K | SEC EDGAR | -0.12% | -4.90% | |
| DaVita Leads the Way in Evaluating Middle Molecule Clearance with Two New Initiatives | Press release | PR Newswire | +0.24% | +1.28% | |
| DaVita Inc. Schedules 3rd Quarter 2025 Investor Conference Call | Press release | PR Newswire | +0.08% | +0.33% | |
| DaVita Honors 25 Years of Clinical Advancement in Chronic Disease Care | Press release | PR Newswire | +0.00% | -0.99% | |
| Form 8-K DAVITA INC. For: Aug 20 | SEC filing · Form 8-K | SEC EDGAR | -0.07% | -1.16% | |
| Linea Launches AI-Driven Care Platform to Cut Heart Failure Readmissions in Half | Press release | PR Web | -5.03% | -4.78% | |
| DaVita Inc. 2nd Quarter 2025 Results | Press release | PR Newswire | -5.03% | -4.78% | |
| Form 10-Q DAVITA INC. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -5.03% | -4.78% | |
| Form 8-K DAVITA INC. For: Aug 05 | SEC filing · Form 8-K | SEC EDGAR | -5.03% | -4.78% | |
| DaVita Inc. Schedules 2nd Quarter 2025 Investor Conference Call | Press release | PR Newswire | -0.19% | -1.85% | |
| Form 8-K DAVITA INC. For: Jul 17 | SEC filing · Form 8-K | SEC EDGAR | -0.19% | -1.85% | |
| Form 11-K DAVITA INC. For: Dec 31 | SEC filing · Form 11-K | SEC EDGAR | +0.28% | +0.97% | |
| Form 8-K DAVITA INC. For: Jun 05 | SEC filing · Form 8-K | SEC EDGAR | -0.55% | +0.69% | |
| DaVita Statement on Government's Kidney Care Choices (KCC) Model Updates | Press release | PR Newswire | -0.07% | -0.46% | |
| Form 8-K DAVITA INC. For: May 23 | SEC filing · Form 8-K | SEC EDGAR | -0.10% | +0.94% | |
| DaVita Inc. Announces Offering of $750 Million Senior Notes | Press release | PR Newswire | -0.17% | +0.33% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the DVA section they belong to.
Where else DVA is measured.
DVA earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Vaxart, Inc. (VXRT) | 341 | -0.81% | 41% |
| Cidara Therapeutics, Inc. (CDTX) | 339 | +0.06% | 52% |
| Lexicon Pharmaceuticals, Inc. (LXRX) | 339 | +0.29% | 51% |
| Cellect Biotechnology Ltd. - American Depositary Shares (APOP) | 337 | -0.42% | 35% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is DaVita Inc.'s median reaction calculated?
Every labeled DVA news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 339 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 53% of DVA's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does DVA's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.